Jpmorgan Chase & CO Quest Diagnostics Inc Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,317,391 shares of DGX stock, worth $592 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,317,391

Previous 3,769,938 14.52%

Holding current value

$592 Million

Previous $517 Million 14.52%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	N/A	547,453 Added 14.52%	4,317,391 $592 Million
Q1 2025 May 12, 2025	BUY	N/A	1,336,025 Added 54.89%	3,769,938 $517 Million
Q4 2024 Feb 12, 2025	BUY	N/A	916,898 Added 60.44%	2,433,913 $334 Million
Q3 2024 Dec 26, 2024	SELL	$137.09 - $137.09 $2.54 Million - $2.54 Million	-18,505 Reduced 1.21%	1,517,015 $208 Million
Q3 2024 Nov 08, 2024	SELL	$137.09 - $137.09 $2.54 Million - $2.54 Million	-18,505 Reduced 1.21%	1,517,015 $208 Million
Q2 2024 Dec 26, 2024	BUY	$125.91 - $144.34 $2.33 Million - $2.67 Million	18,505 Added 1.22%	1,535,520 $210 Million
Q2 2024 Aug 12, 2024	SELL	$125.91 - $144.34 $36.3 Million - $41.6 Million	-287,990 Reduced 15.79%	1,535,520 $210 Million
Q1 2024 Dec 26, 2024	BUY	$123.78 - $142.11 $37.9 Million - $43.6 Million	306,495 Added 20.2%	1,823,510 $243 Million
Q1 2024 May 10, 2024	SELL	$123.78 - $142.11 $5.47 Million - $6.28 Million	-44,220 Reduced 2.37%	1,823,510 $243 Million
Q4 2023 Dec 26, 2024	BUY	$120.62 - $141.12 $42.3 Million - $49.5 Million	350,715 Added 23.12%	1,867,730 $258 Million
Q4 2023 Feb 12, 2024	SELL	$120.62 - $141.12 $16.1 Million - $18.9 Million	-133,617 Reduced 6.68%	1,867,730 $258 Million
Q3 2023 Nov 14, 2023	BUY	$121.86 - $144.92 $65.6 Million - $78 Million	538,377 Added 36.8%	2,001,347 $244 Million
Q2 2023 Aug 11, 2023	BUY	$130.56 - $146.84 $619,637 - $696,902	4,746 Added 0.33%	1,462,970 $206 Million
Q1 2023 May 18, 2023	BUY	$131.53 - $155.76 $6.87 Million - $8.14 Million	52,234 Added 3.72%	1,458,224 $206 Million
Q1 2023 May 11, 2023	BUY	$131.53 - $155.76 $145 Million - $172 Million	1,102,169 Added 362.77%	1,405,990 $199 Million
Q4 2022 Feb 13, 2023	SELL	$123.31 - $157.26 $101,114 - $128,953	-820 Reduced 0.27%	303,821 $47.5 Million
Q3 2022 Nov 14, 2022	BUY	$121.77 - $141.1 $2.56 Million - $2.96 Million	21,010 Added 7.41%	304,641 $37.4 Million
Q2 2022 Aug 11, 2022	SELL	$127.07 - $145.39 $8.45 Million - $9.67 Million	-66,490 Reduced 18.99%	283,631 $37.7 Million
Q1 2022 May 11, 2022	SELL	$129.09 - $164.35 $13.7 Million - $17.5 Million	-106,463 Reduced 23.32%	350,121 $47.9 Million
Q4 2021 Feb 10, 2022	BUY	$140.36 - $173.01 $11.9 Million - $14.6 Million	84,654 Added 22.76%	456,584 $79 Million
Q3 2021 Nov 12, 2021	BUY	$132.95 - $158.0 $49.4 Million - $58.8 Million	371,930 New	371,930 $54 Million

Others Institutions Holding DGX

# of Institutions

1,129

Shares Held

105M

Call Options Held

487K

Put Options Held

534K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Quest Diagnostics Inc Transaction History